Postmenopausal Hormone Therapy: Impact on Menopause-Related Symptoms, Chronic Disease and Quality of Life

Author： Marius Jan van der Mooren   Kenemans P.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.8, 2004-01, pp. : 821-836

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy: In the Management of Postmenopausal Women with Climacteric Symptoms in the UK

By Plumb J.M.   Guest J.F.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 477-486

Adis International

Access to resources Recommend Favorite

The Impact of Fragility Fracture on Health-Related Quality of Life: The Importance of Antifracture Therapy

By Ted Xenodemetropoulos   Shawn Davison   George Ioannidis   Jonathan D. Adachi  

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 711-730

Adis International

Access to resources Recommend Favorite

A Review of the Health-Related Quality of Life and Economic Impact of Parkinson's Disease

By Dowding Clare H.   Shenton Claire L.   Salek Sam S.  

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 693-721

Adis International

Access to resources Recommend Favorite

Menopause-related QOL improved with bazedoxifene combo

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 589, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Growth Hormone Therapy and Quality of Life in Adults and Children

By Radcliffe D.J.  

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 499-524

Adis International

Access to resources Recommend Favorite